Skip to main content
geoopen

Identification of recurrent GBM patients that may benefit from Bevacizumab and CCNU: A report from the BELOB trial by the Dutch Neurooncology Group

GEO Series GSE72951. Homo sapiens. 112 samples. Type: Expression profiling by array.

ShareScore

24/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
4
Harmonization
8
Access
4
Reuse readiness
0
Engagement
8

Topics

Dataset details

Repository
geo
Published
January 19, 2016
License
GEO-Open
DOI
geo/GSE72951

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.